Aspiriant LLC’s iShares Core Conservative Allocation ETF AOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Hold
8,060
0.01% 305
2026
Q1
$322K Hold
8,060
0.01% 269
2025
Q4
$323K Hold
8,060
0.01% 268
2025
Q3
$324K Hold
8,060
0.01% 243
2025
Q2
$315K Buy
+8,060
New +$305K 0.01% 245
2022
Q1
Sell
-9,014
Closed -$361K 278
2021
Q4
$361K Sell
9,014
-2,501
-22% -$99.8K 0.02% 209
2021
Q3
$455K Buy
+11,515
New +$461K 0.03% 166

Other funds holding AOK

Aspiriant LLC's AOK Position: Q2 2026 in Review

Aspiriant LLC held its iShares Core Conservative Allocation ETF (AOK) position steady in Q2 2026 at 8,060 shares worth $334K. The position accounts for 0.01% of the portfolio, ranked #305.

Aspiriant LLC first reported a position in AOK in Q3 2021 and has held it in 7 quarters since. The position peaked at $455K in Q3 2021. 184 funds tracked by Wall St. Rank hold AOK as of Q2 2026.

  • Aspiriant LLC held 8,060 shares of iShares Core Conservative Allocation ETF worth $334K as of Q2 2026.
  • Aspiriant LLC left its iShares Core Conservative Allocation ETF share count unchanged in Q2 2026.
  • iShares Core Conservative Allocation ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #305 holding.
  • Aspiriant LLC first reported a position in iShares Core Conservative Allocation ETF in Q3 2021 and has held it in 7 quarters since.
  • Aspiriant LLC's iShares Core Conservative Allocation ETF position peaked at $455K in Q3 2021.
  • 184 funds tracked by Wall St. Rank held iShares Core Conservative Allocation ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.